1/281
Psychopathology and Diagnostic Reasoning- Week 8/ Module 3
Potential problematic alcohol use using Cut down, Annoyed, Guilty, and Eye-opener questions; screens for potential alcohol and substance use disorders
Partial mu-opioid receptor (full opioid agonists= heroin/oxycodone) agonist that reduces withdrawal and craving with a ceiling effect on respiratory depression; does not cause intense euphoria
Competitive opioid receptor antagonist; binds tightly to mu-opioid receptors in the CNS without activating them; eliminates the high by blocking exogenous opioids from binding to the receptors. Blocking the reward pathway.
The patient must be opioid-free for 7-14 days to avoid sudden, severe opioid withdrawal
Acts as a functional glutamate antagonist and GABA-A/GABA-B modulator to restore chemical balance in the brain during alcohol recovery; Chronic alcohol use causes an overproduction of the excitatory neurotransmitter glutamate and upregulates NMDA.
Alcohol -> converted in liver to toxic acetaldehyde by alcohol dehydrogenase (ALDH) -> rapidly broken down into harmless acetic acid by ALDH. Disulfiram irreversibly inactivates ALDH. If alcohol is consumed while taking disulfiram, acetaldehyde accumulates rapidly in the bloodstream (5/10x)
Private, nonjudgmental interviewing can build trust, encourage honest disclosures, and ensure young people actually seek help rather than hiding their behavior or avoiding care. Although clinicians must explain mandatory reporting obligations (harm to self or others, child abuse/neglect)
Alcohol, benzodiazepines, barbiturates, non-benzodiazepine sleep medications (Z-drugs; Ambien), and opioids/ narcotics.
Enhances GABA-A inhibitory signaling (reduces neuronal firing) and inhibits NMDA glutamate signaling (lowering overall brain excitation and impairing memory formation)
Confusion, oculomotor abnormalities (rapid eye movements/nystagmus, double vision, or eye muscle weakness), and ataxia (loss of muscle coordination, unsteady gait, and balance problems), although the complete triad is often absent
Muscle aches, lacrimation (watery eyes), rhinorrhea, yawning, sweating, dilated pupils, piloerection, abdominal cramps, diarrhea, and restlessness
Activates nicotinic acetylcholine receptors and stimulates reward pathways through increased dopamine signaling= makes other activities feel much more rewarding than they normally would
Elevated alertness, euphoria, tachycardia, hypertension, mydriasis (pupil dilation), agitation, decreased appetite, and insomnia
Blocks reuptake of dopamine, norepinephrine, and serotonin, increasing monoaminergic signaling; serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) and a voltage-gated sodium channel blocker
Increases monoamine release and reverses transporter activity (these transporters pump dopamine and norepinephrine outward into the synaptic cleft), especially for dopamine, norepinephrine, and serotonin transporters
A rare condition in which a person experiences lasting or recurring visual disturbances and perceptual distortions long after the effects of a hallucinogenic or mind-altering drug have worn off
An increased response to a substance after repeated exposure instead of a lower, potentially contributing to stimulant-related behavioral effects
Supports executive control, judgment, and inhibition, with its dysfunction being a core driver of the loss of control, compulsive drug-seeking, and impaired decision-making seen in addiction.
Positive reinforcement adds a rewarding effect (euphoria from a high/ social at a party), while negative reinforcement removes an unpleasant state such as withdrawal, anxiety, pain, or stress